Document:

<PAGE>
                                                                   EXHIBIT 10.57

                      THE CIT GROUP/ BUSINESS CREDIT, INC.
                     1211 Avenue of the Americas, 22nd Floor
                            New York, New York 10036

                                   Dated as of
                               September 14, 2001

                      Re: Waiver and Amendment Number Four
                    to Financing Agreement and Loan Documents

TWIN LABORATORIES INC.
150 Motor Parkway
Hauppauge, New York 11788

Gentlemen:

Reference is made to the Financing Agreement between The CIT Group/Business
Credit, Inc. as lender and agent thereunder ("Agent"), the other lenders party
thereto ("Lenders"), and Twin Laboratories Inc. and certain of its subsidiaries,
as borrowers thereunder (collectively, the "Companies"), dated as of March 29,
2001, as the same has been amended (the "Financing Agreement"). Capitalized
terms used herein and not otherwise defined herein shall have the meanings
ascribed to such terms in the Financing Agreement.

Agent, Lenders and the Companies wish to waive and amend certain provisions of
the Loan Documents.

Therefore, pursuant to mutual agreement, it is hereby agreed as follows:

I. Waiver of Section 6.11(a). Lenders hereby waive the applicability of Section
6.11(a) as to, but only as to, the periods ended May 31, 2001, and June 30,
2001.

II. Increase in Availability Reserve. In addition to all other reserves
established under the Availability Reserve, an additional Availability Reserve
of $3,000,000 is hereby established.

III. Amendment of Section 6.11(a). Section 6.11(a) of the Financing Agreement is
hereby amended to read as follows:

      (a) maintain at the end of each month, on a cumulative basis for each
      month during Fiscal Year 2001 and on a rolling, trailing 12-month basis
      thereafter, EBITDA of not less than the amounts set forth below for the
      applicable period:

<TABLE>
<CAPTION>
             Period                                                  Amount
             ------                                                  ------
--------------------------------------------------------------------------------
<S>                                                              <C>
Cumulative for Fiscal Year 2001, calculated as of                <$12,506,000>
month-end, July, 2001
--------------------------------------------------------------------------------
</TABLE>

                                       1
<PAGE>

<TABLE>
<S>                                                              <C>
--------------------------------------------------------------------------------
Cumulative for Fiscal Year 2001, calculated as of                <$11,500,000>
month-end, August, 2001
--------------------------------------------------------------------------------
Cumulative for Fiscal Year 2001, calculated as of                 <$8,200,000>
month-end, September, 2001
--------------------------------------------------------------------------------
Cumulative for Fiscal Year 2001, calculated as of                 <$8,200,000>
month-end, October, 2001
--------------------------------------------------------------------------------
Cumulative for Fiscal Year 2001, calculated as of                 <$8,200,000>
month-end, November, 2001
--------------------------------------------------------------------------------
Cumulative for Fiscal Year 2001, calculated as of                 <$5,300,000>
month-end, December, 2001
--------------------------------------------------------------------------------
Cumulative trailing 12 months thereafter, acalculated as          $15,000,000
of each month end
--------------------------------------------------------------------------------
</TABLE>

IV. Confirmation of Guaranties. By execution below, the Companies and the other
parties constituting Guarantors hereby each confirm that each of their
respective guaranties executed and delivered in connection with the Financing
Agreement remains in full force and effect notwithstanding the execution,
delivery and performance by the Companies of this Letter Amendment and the
Financing Agreement as amended hereby.

V. General Terms.

      1. To the extent any of the terms and provisions of the Financing
Agreement and/or the Loan Documents conflict or are inconsistent with the terms
hereof, the terms of this Waiver and Amendment shall govern.

      2. The effectiveness of this Waiver and Amendment is conditioned upon
receipt by Agent of:

            (a) an executed counterpart of this Waiver and Amendment executed by
each Company and Guarantor;

            (b) an executed amendment to the Blechmans Agreement Regarding
Letters of Credit, in form and substance satisfactory to the Lenders; and

            (c) payment, for the account of Lenders, of a fully earned and
non-refundable fee of $100,000 in consideration of this Waiver and Amendment.

                                       2
<PAGE>

      3. This Waiver and Amendment may be executed in two or more counterparts,
each of which shall constitute an original but all of which when taken together
shall constitute but one agreement, and shall become effective when copies
hereof which, when taken together, bear the original signatures of each of the
parties hereto are delivered to Agent.

      4. Except as set forth herein no other change in the terms or provisions
of the Financing Agreement or any other Loan Document is intended or implied. If
the foregoing is in accordance with your understanding, please so indicate by
signing and returning the enclosed copy of this Waiver and Amendment.

                                        Very truly yours,

                                        THE CIT GROUP/BUSINESS CREDIT, INC.

                                        By:________________________________

                                        Title:_______________________________

CONGRESS FINANCIAL CORPORATION

By: __________________________
Title:

GMACC COMMERCIAL CREDIT, LLC

By: __________________________
Title:

                                       3
<PAGE>

AGREED:

TWIN LABORATORIES INC.,
a Utah corporation

By: _______________________________
Title:

TWINLAB DIRECT, INC.,
a Florida corporation

By: _______________________________
Title:

TWINLAB MAILORDER, INC.,
a  California corporation

By: _______________________________
Title:

HEALTH FACTORS INTERNATIONAL, INC.,
a Delaware corporation

By: _______________________________
Title:

BRONSON LABORATORIES, INC.,
a Delaware corporation

By: _______________________________
Title:

TWINLAB CORPORATION,
a Delaware corporation

By: _______________________________
Title:

                                       4
<PAGE>

TWINLAB FSC INC.,
a Barbados corporation

By: _______________________________
Title:

                                       5<PAGE>
                                                                   EXHIBIT 10.58

                      THE CIT GROUP/ BUSINESS CREDIT, INC.
                       300 South Grand Avenue, Third Floor
                          Los Angeles, California 90071

                                   Dated as of
                                February 28, 2002

                      Re: Waiver and Amendment Number Five
                    to Financing Agreement and Loan Documents

TWIN LABORATORIES INC.
150 Motor Parkway
Hauppauge, New York 11788

Gentlemen:

Reference is made to the Financing Agreement between The CIT Group/Business
Credit, Inc. as lender and agent thereunder ("Agent"), the other lenders party
thereto ("Lenders"), and Twin Laboratories Inc. ("Twinlab") and certain of its
subsidiaries, as borrowers thereunder (collectively, the "Companies"), dated as
of March 29, 2001, as the same has been amended (the "Financing Agreement").
Capitalized terms used herein and not otherwise defined herein shall have the
meanings ascribed to such terms in the Financing Agreement.

Agent, Lenders and the Companies wish to waive and amend certain provisions of
the Loan Documents.

Therefore, pursuant to mutual agreement, it is hereby agreed as follows:

I. Waiver of Sections 6.10(d) and 6.14. Lenders hereby waive the applicability
of Sections 6.10(d) and 6.14 with respect to the sale of substantially all of
the assets of Twinlab Mailorder, Inc. (f/k/a PR Nutrition, Inc.), a California
corporation ("Mailorder") and Twinlab Direct, Inc. (f/k/a Changes International,
Inc.), a Florida corporation ("Direct"), on the terms and conditions previously
disclosed to Agent by the Companies. Lenders further agree that upon the
effective date of this Waiver and Amendment, all liens, claims and encumbrances
of Agent and the Lenders upon the capital stock and assets of Mailorder and
Direct shall be released and of no further force and effect, and Agent shall, at
the Companies' cost and expense, execute and deliver any and all such lien
releases, UCC-1 financing statement termination statements and other instruments
and agreements as reasonably requested by the Companies to effect such release
of liens, claims and encumbrances.

II. Waiver of Section 6.11(a). Lenders hereby waive the applicability of
Sections 6.11(a) as to, but only as to, the period ended December 31, 2001.

III. Amendment of Definition of Availability Reserve. Clause (d) of the
definition of

                                       1
<PAGE>

Availability Reserve set forth in Section 1 of the Agreement is hereby replaced
in its entirety with the following:

      (d) $5,000,000 from and after March 15, 2002, which reserve shall be
      reduced (if no Event of Default shall have occurred and be continuing and
      if Availability shall not have otherwise materially decreased (in the
      judgment of Agent) due to a deterioration of the Borrowing Base which
      occurs prior to the required date of satisfaction of the applicable
      Benchmark Condition) to the following amounts upon satisfaction of the
      following applicable conditions: (A) to $3,750,000 from March 15, 2002
      through March 31, 2002; (B) to $2,500,000 from April 1, 2002 through April
      30, 2002 if the Benchmark Conditions - 3/31/02 have been satisfied; (C) to
      $1,250,000 from May 1, 2002 through May 31, 2002 if the reserve has been
      reduced under clause (B) and if the Benchmark Conditions - 4/15/02 and
      Benchmark Conditions - 4/30/02 have been satisfied; and (D) to zero from
      June 1, 2002 and thereafter if the reserve has been reduced under the
      foregoing clauses (B) and (C), provided that any reduction of the reserve
      referenced in this clause (d) shall not be deemed to be a limitation on
      the right of Agent or the Lenders to establish reserves under other
      provisions hereof;

IV. Amendment to Add Definitions of Benchmark Conditions and Memorandum. Section
1 of the Financing Agreement is hereby amended to add the definitions of
Benchmark Conditions - 3/31/02, Benchmark Conditions - 4/15/02, Benchmark
Conditions - 4/30/02, and Memorandum set forth on Exhibit 1 to this Waiver and
Amendment.

V. Amendment to Interest Rate. The definition of Chase Bank Rate Margin is
hereby replaced in its entirety with the following:

      Chase Bank Rate Margin shall mean one and three quarters (1.75) percentage
      points.

VI. Amendment to Definition of EBITDA. The definition of EBITDA in Section 1 of
the Financing Agreement is hereby amended to exclude therefrom any and all
restructuring charges, as determined in accordance with GAAP.

VII. Amendment of Section 6.11(a). Section 6.11(a) of the Financing Agreement is
hereby amended to read as follows:

      (a) maintain at the end of each month, on a cumulative basis calculated on
      a rolling, trailing 12-month basis, EBITDA of not less than the amounts
      set forth below for the applicable period:

<TABLE>
<CAPTION>
              Period                                       Amount
              ------                                        ------
--------------------------------------------------------------------------------
<S>                                                      <C>
Calculated as of January 31, 2002                        <$8,050,000>
--------------------------------------------------------------------------------
Calculated as of February 28, 2002                       <$8,400,000>
--------------------------------------------------------------------------------
Calculated as of March 31, 2002                          <$6,550,000>
--------------------------------------------------------------------------------
Calculated as of April 30, 2002                          <$6,350,000>
--------------------------------------------------------------------------------
</TABLE>

                                       2
<PAGE>

<TABLE>
<S>                                                      <C>
--------------------------------------------------------------------------------
Calculated as of May 31, 2002                            <$2,200,000>
--------------------------------------------------------------------------------
Calculated as of June 30, 2002                            $1,700,000
--------------------------------------------------------------------------------
Calculated as of July 31, 2002                            $3,650,000
--------------------------------------------------------------------------------
Calculated as of August 31, 2002                          $3,050,000
--------------------------------------------------------------------------------
Calculated as of September 30, 2002                       $3,100,000
--------------------------------------------------------------------------------
Calculated as of October 31, 2002                         $4,850,000
--------------------------------------------------------------------------------
Calculated as of November 30, 2002                        $7,000,000
--------------------------------------------------------------------------------
Calculated as of December 31, 2002                       $11,100,000
--------------------------------------------------------------------------------
Calculated as of each month end thereafter               $15,000,000
--------------------------------------------------------------------------------
</TABLE>

VIII. Confirmation of Guaranties. By execution below, the Companies and the
other parties constituting Guarantors (other than Mailorder and Direct) hereby
each confirm that each of their respective guaranties executed and delivered in
connection with the Financing Agreement remains in full force and effect
notwithstanding the execution, delivery and performance by the Companies of this
Letter Amendment and the Financing Agreement as amended hereby.

IX. Amendment of Loan Documents to Remove Mailorder and Direct. The Financing
Agreement and the other Loan Documents are hereby amended such that Mailorder
and Direct are no longer a party thereto, each and every reference to Mailorder
and Direct therein is deleted, each reference to the Companies does not include
Mailorder and Direct, and Mailorder and Direct are released from all obligations
under the Financing Agreement and the other Loan Documents.

X. General Terms.

      1. To the extent any of the terms and provisions of the Financing
Agreement and/or the Loan Documents conflict or are inconsistent with the terms
hereof, the terms of this Waiver and Amendment shall govern.

      2. The effectiveness of this Waiver and Amendment is conditioned upon
receipt by Agent of:

            (a) an executed counterpart of this Waiver and Amendment executed by
each Company and Guarantor;

            (b) evidence of notification, in writing, by Agent or Twinlab to the
Blechmans of the terms and execution of this Waiver and Amendment; and

            (c) payment, for the account of Lenders, of a fully earned and
non-refundable fee of $200,000 in consideration of this Waiver and Amendment.

                                       3
<PAGE>

      3. This Waiver and Amendment may be executed in two or more counterparts,
each of which shall constitute an original but all of which when taken together
shall constitute but one agreement, and shall become effective when copies
hereof which, when taken together, bear the original signatures of each of the
parties hereto are delivered to Agent.

      4. Except as set forth herein no other change in the terms or provisions
of the Financing Agreement or any other Loan Document is intended or implied. If
the foregoing is in accordance with your understanding, please so indicate by
signing and returning the enclosed copy of this Waiver and Amendment.

                                      Very truly yours,

                                      THE CIT GROUP/BUSINESS CREDIT, INC.

                                      By:________________________________

                                      Title:_______________________________

CONGRESS FINANCIAL CORPORATION

By: _______________________________
Title:

GMACC COMMERCIAL CREDIT, LLC

By: _______________________________
Title:

                                       4
<PAGE>

AGREED:

TWIN LABORATORIES INC.,

a Utah corporation

By: _______________________________
Title:

HEALTH FACTORS INTERNATIONAL, INC.,

a Delaware corporation

By: _______________________________
Title:

BRONSON LABORATORIES, INC.,

a Delaware corporation

By: _______________________________
Title:

TWINLAB CORPORATION,

a Delaware corporation

By: _______________________________
Title:

                                       5
<PAGE>

                                    EXHIBIT 1

               Definitions of Benchmark Conditions and Memorandum

Benchmark Conditions - 3/31/02 shall mean the achievement of the following, as
evidenced by a Memorandum received by Agent on or before March 31, 2002:

(a) with respect to the Companies' accounts receivable the following benchmarks
will be achieved:

      i.    Twinlab will have hired two temporary employees and assigned one
            full time employee to research, classify and document customer
            deductions taken prior to December 31, 2001; and

      ii.   Twinlab will have reduced the total of un-issued credit memos and
            unapplied charge backs over 90 days outstanding from $3,800,000 (at
            December 31, 2001) to $1,900,000; and

      iii.  Twinlab will have established a new department to process
            reclamations as recommended by the PriceWaterhouseCoopers report
            dated November, 2001 and provided to the Agent during the January 8,
            2002 meeting; and

      iv.   Twinlab will have implemented a new policy for damages and
            reclamations. Implementation will include drafting policy,
            communication to customers and establishing an accrual methodology;
            and

      v.    Twinlab will have implemented an accrual methodology for other
            deductions that will accrue estimated credits by customer.

(b) With respect to the Companies' inventory the following benchmarks will be
achieved:

      i.    Twinlab will have reduced the reserve to $10 million ($15.7 million
            at September 30, 2001; $14.6 million at December 31, 2001) through
            the following steps:

      o     Identification of rework opportunities and write down of rework
            inventory to new net realizable value; and

      o     Disposal of non-useable inventory; and

      o     Write down of remaining inventory to its fair value.

      Benchmark Conditions - 4/15/02 shall mean the achievement of the
      following, as evidenced by a Memorandum received by Agent on or before
      April 15, 2002:

                                       6
<PAGE>

(a) With respect to the Companies' inventory the following benchmarks will be
achieved:

      i.    Twinlab will prepare an analysis on the top 30 SKUs by volume that
            will analyze current versus projected required raw material lead
            times, production cycle times and required finished goods days of
            supply; and

      ii.   Twinlab will prepare an analysis on the top 25 supply items by
            volume that will analyze current versus projected supply material
            lead times, and required days of supply; and

      iii.  Twinlab will take the analysis prepared in step i. and ii. and begin
            implementation of projected required target levels.

(b) With respect to the Companies' plant, property and equipment:

      i.    Announce plan to sell or dispose of Tempe, AZ facility; and

      ii.   Prepare analysis to determine under-utilized equipment; and

      iii.  Develop a plan of action steps to sell or retire under-utilized
            equipment including under-utilized leased equipment; and.

      iv.   Contact five potential buyers and attempt to sell the under-utilized
            equipment; and

      v.    For leased manufacturing equipment, contact lessor to renegotiate
            lease terms to a more favorable cash flow position or the
            possibility to return equipment to lessor.

Benchmark Conditions - 4/30/02 shall mean the achievement of the following, as
evidenced by a Memorandum received by Agent on or before April 30, 2002:

(a) With respect to the Companies' accounts receivable the following benchmarks
will be achieved:

      i.    Twinlab will reduce the total of un-issued credit memos and
            unapplied charge backs over 90 days outstanding to under $1,500,000
            ($3,800,000 at December 31, 2001); and

      ii.   Twinlab will prepare a report of un-issued credit memos and
            unapplied charge backs over 90 days and provide such report to
            Agent. (Report to include unapplied credits greater than $100,000
            and greater than 90 days old).

Memorandum shall mean a report prepared by Deloitte & Touche and delivered to
the Company. This report will list specific procedures performed to verify
Benchmark Conditions and provide the result of these procedures in a format
consistent with the American Institute of Certified Public Accountants Report on
Agreed Upon Procedures.

                                       7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00037-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00037-of-00352.parquet"}]]